Varicella Vaccine
Author Information
Author(s): Patrick Duff
Primary Institution: University of Florida, College of Medicine
Hypothesis
The varicella vaccine is effective in preventing varicella infection and its complications.
Conclusion
The varicella vaccine is approximately 70-80% effective in preventing or reducing the severity of natural varicella infections.
Supporting Evidence
- The vaccine has shown seroconversion rates of 90% and 97% after 1 and 2 doses in leukemic children.
- Immunity following vaccination has been shown to last for at least 20 years.
- None of the vaccinated children developed varicella during a 9-month observation period.
Takeaway
The varicella vaccine helps protect kids from chickenpox, which can be really bad for some people, especially those who are sick.
Methodology
The study involved administering the varicella vaccine to various groups, including children with leukemia, and measuring seroconversion rates.
Limitations
The study does not address long-term effects beyond the follow-up periods mentioned.
Participant Demographics
Participants included healthy children, adolescents, adults, and children with leukemia.
Statistical Information
P-Value
<10-9
Statistical Significance
p<10-9
Want to read the original?
Access the complete publication on the publisher's website